MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Abbott Laboratories

Geschlossen

BrancheGesundheitswesen

128.47 1.01

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

128.47

Max

129.22

Schlüsselkennzahlen

By Trading Economics

Einkommen

454M

1.8B

Verkäufe

784M

11B

KGV

Branchendurchschnitt

16.484

36.442

EPS

1.26

Dividendenrendite

1.75

Gewinnspanne

15.967

Angestellte

114,000

EBITDA

383M

3B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+14.07% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.75%

3.00%

Nächste Dividendenausschüttung

17. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1B

229B

Vorheriger Eröffnungskurs

127.46

Vorheriger Schlusskurs

128.47

Nachrichtenstimmung

By Acuity

57%

43%

296 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Abbott Laboratories Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Okt. 2025, 12:02 UTC

Ergebnisse

Abbott Labs Posts Higher 3Q Sales, Reaffirms Outlook

17. Juli 2025, 12:10 UTC

Ergebnisse

Abbott Labs Pares Outlook, Logs 2Q Profit Gains

15. Okt. 2025, 16:15 UTC

Ergebnisse

Abbott Stock Drops Despite Earnings. Baby-Formula Sales Took a Hit. -- Barrons.com

15. Okt. 2025, 12:25 UTC

Ergebnisse

Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway. -- Barrons.com

15. Okt. 2025, 11:32 UTC

Ergebnisse

Abbott Labs Still Sees 2025 Organic Sales Up 6%-7% Including Covid-19 Testing-Related Sales >ABT

15. Okt. 2025, 11:32 UTC

Ergebnisse

Abbott Labs Still Sees 2025 Organic Sales Up 7.5%-8% Excluding Covid-19 Testing-Related Sales >ABT

15. Okt. 2025, 11:31 UTC

Ergebnisse

Abbott Labs Sees 2025 Adj EPS $5.12-Adj EPS $5.18 >ABT

15. Okt. 2025, 11:30 UTC

Ergebnisse

Abbott Labs 3Q Adjusted Operating Margin 23% >ABT

15. Okt. 2025, 11:30 UTC

Ergebnisse

Abbott Labs Reaffirms Full-Year Guidance >ABT

15. Okt. 2025, 11:30 UTC

Ergebnisse

Abbott Labs 3Q Organic Sales Growth Up 5.5% >ABT

15. Okt. 2025, 11:30 UTC

Ergebnisse

Abbott Labs 3Q Sales $11.37B >ABT

15. Okt. 2025, 11:30 UTC

Ergebnisse

Abbott Labs 3Q Adj EPS $1.30 >ABT

15. Okt. 2025, 11:30 UTC

Ergebnisse

Abbott Labs 3Q Net $1.64B >ABT

15. Okt. 2025, 11:30 UTC

Ergebnisse

Abbott Labs 3Q EPS 94c >ABT

11. Okt. 2025, 00:18 UTC

Akquisitionen, Fusionen, Übernahmen

Why Biotech May Be Back -- Barrons.com

17. Juli 2025, 13:14 UTC

Ergebnisse

Abbott Labs Stock Falls After Earnings. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17. Juli 2025, 12:16 UTC

Ergebnisse

Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17. Juli 2025, 11:32 UTC

Ergebnisse

Abbott Labs Sees 3Q Adj EPS $1.28-Adj EPS $1.32 >ABT

17. Juli 2025, 11:32 UTC

Ergebnisse

Abbott Labs: See Momentum Carrying Into 2026 >ABT

17. Juli 2025, 11:31 UTC

Ergebnisse

Abbott Labs Sees 2025 Organic Sales Up 7.5%-8%, Excluding Covid-19 Testing-Related Sales >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs 2Q Organic Sales Rose 6.9% >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs 2Q Adjusted Operating Margin 22.9% >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs 2Q Adjusted Gross Margin 57% >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs 2Q Organic Sales Growth Up 6.9% >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs 2Q Sales $11.14B >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs 2Q Net $1.78B >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs 2Q Adj EPS $1.26 >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs Sees FY Adj EPS $5.10-Adj EPS $5.20 >ABT

17. Juli 2025, 11:30 UTC

Ergebnisse

Abbott Labs 2Q EPS $1.01 >ABT

17. Juli 2025, 09:08 UTC

Heiße Aktien

Stocks to Watch Thursday: TSMC, United Airlines, Sarepta -- WSJ

Peer-Vergleich

Kursveränderung

Abbott Laboratories Prognose

Kursziel

By TipRanks

14.07% Vorteil

12-Monats-Prognose

Durchschnitt 146.63 USD  14.07%

Hoch 162 USD

Tief 136 USD

Basierend auf 20 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Abbott Laboratories – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

20 ratings

18

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

132.82 / 134.43Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Neutral Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

296 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat